BD Diagnostics, Lab21 to Develop MDx for BD Max System
August 03, 2011
BD Diagnostics, Lab21 to Develop MDx for BD Max System
Today's announcement is in line with BD's plans to bring new assays to the BD Max System in a "broad range" of diseases.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- BD, Lab21 Team on Oncology Assays
October 15, 2012 / GenomeWeb Daily News - BD Diagnostics, Lab21 Developing Aspergillus MDx for BD Max Platform
August 4, 2011 / PCR Insider - Lab21 to Develop Aspergillus Assay for Second IVD Company
April 12, 2012 / PCR Insider - BD Diagnostics, Diagenode to Co-develop Assays on BD Max System
May 9, 2011 / GenomeWeb Daily News - Nanosphere Reaches Distribution, Collaboration Deal with Hitachi; Completes $4.7M Financing
May 14, 2013 / GenomeWeb Daily News